Karolinska Development invests in Oss-Q
(Thomson Reuters ONE) -
STOCKHOLM, SWEDEN - February 21, 2012. Oss-Q AB, a Swedish medical device
company focusing on implants for bone healing, has received SEK 9m in financing
through a new share issue directed to Karolinska Development as lead investor,
together with Almi Invest and Uppsala University Holding Company (UUAB). The new
share issue enables Oss-Q to advance the development of its first implant
product and prepare the company for market launch.
Oss-Q is developing a novel implant technology and related bioceramic
innovations, based on research at Karolinska University Hospital and Uppsala
University. The vision of Oss-Q is to convert the technology into
differentiating products for bone repair and to build a niche company in
orthopedics, with its own sales starting with skull surgery. A foothold in skull
surgery will prepare the company for subsequent development in other orthopedic
areas, such as fracture repair. The market for biomaterials products in
orthopedics was worth more than EUR 1.25b in 2011.
Bo Qwarnström, CEO of Oss-Q:
"We are delighted that Karolinska Development joins our circle of owners. The
industrial know-how, network and resources of Karolinska Development will be
important for taking Oss-Q to the next stage in our commercial development. We
are also happy to have Almi Invest as a new owner and that UUAB continues to
invest in Oss-Q."
Torbjörn Bjerke, CEO of Karolinska Development:
"I am impressed with the implant technology that Oss-Q has developed and with
the people behind it. The technology has applications in a range of implants in
bone defect indications where current products often result in poor healing. The
early clinical data in skull defects are very promising and I strongly believe
this product has the potential to reduce the rate of complications, patient
suffering and thereby hospital costs."
After the investment, Karolinska Development owns 15.7 percent of Oss-Q,
including indirect ownership through KCIF Co-Investment Fund.
For further information, please contact:
Bo Qwarnström, CEO, Oss-Q AB
Phone: +46 (0) 76 899 85 87, e-mail: info(at)oss-q.com
Torbjörn Bjerke, CEO, Karolinska Development AB
Phone: +46 (0) 72 744 41 23, e-mail: torbjorn.bjerke(at)karolinskadevelopment.com
TO THE EDITORS
About Oss-Q
Oss-Q was founded by researchers at Uppsala University and Karolinska University
Hospital. The company is developing pioneering implants for bone healing with an
initial focus on skull surgery.
About Karolinska Development
Karolinska Development aims to create value for investors, patients, and
researchers by developing innovations from world class science into products
that can be sold or out-licensed with high returns. The business model is to:
SELECT the most commercially attractive medical innovations; DEVELOP innovations
to the stage where the greatest return on investment can be achieved; and
COMMERCIALIZE the innovations through the sale of companies or out-licensing of
products. An exclusive deal flow agreement with Karolinska Institutet
Innovations AB, along with other cooperation agreements with leading Nordic
universities, delivers a continuous flow of innovations. Today, the portfolio
consists of 36 projects, of which 14 are in clinical development. For more
information, please visit www.karolinskadevelopment.com.
Karolinska Development is listed on NASDAQ OMX. Karolinska Development may be
required to disclose the information provided herein pursuant to the Securities
Markets Act.
Press Release as PDF:
http://hugin.info/143071/R/1587707/498028.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Karolinska Development AB (publ) via Thomson Reuters ONE
[HUG#1587707]
Unternehmensinformation / Kurzprofil:
Datum: 21.02.2012 - 08:01 Uhr
Sprache: Deutsch
News-ID 116518
Anzahl Zeichen: 4567
contact information:
Town:
Solna
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 200 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Karolinska Development invests in Oss-Q"
steht unter der journalistisch-redaktionellen Verantwortung von
Karolinska Development AB (publ) (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
